Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal neoplasm, connective tissue neoplasm, dermatofibrosarcoma protuberans, digestive system disorder, digestive system neoplasm, epithelial neoplasm, fibrosarcoma, gastric neoplasm, head and neck squamous cell carcinoma, histiocytoma, intestinal disorder, leiomyosarcoma, liposarcoma, lung disorder, lung neoplasm, myomatous neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, solitary fibrous tumor, squamous cell carcinoma, stomach disorder, undifferentiated pleomorphic sarcomaRecruitingPhase 12026-06-11NCT06789172

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Epkin1
Precision For Medicine1

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Chris O'Brien LifehouseSydneyAustralia2
Churchill HospitalOxfordUnited Kingdom17
Leicester Royal InfirmaryLeicesterUnited Kingdom35
Linear Clinical ResearchPerthAustralia12
MD Anderson Cancer CenterHoustonUnited States589
Precision NextGen Oncology and Research CenterBeverly HillsUnited States5
Sarcoma Oncology CenterSanta MonicaUnited States17
The BeatsonGlasgowUnited Kingdom3
The ChristieManchesterUnited Kingdom7
University College London HospitalLondonUnited Kingdom32